Gynecology/Obstetrics CME

Credits: 1.00 CME
Medical Learning Institute, Inc.
Realizing the Potential of CDK 4/6 Inhibitor Therapy in Breast Cancer: An Examination of the Evidence That Is Informing Real-World Practice
September 30, 2020
Credits: 1.00 CNE
Medical Learning Institute, Inc.
Rethinking Patient Care in Endometrial and Cervical Cancer: How Nurses Can Lead the Targeted and Immunotherapeutic Revolution
August 5, 2020
Credits: 1.00 CME
Medical Learning Institute, Inc.
Current and Emerging Therapies for Endometriosis and Uterine Fibroids: What Do You Need to Know?
August 3, 2020
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Evidence Informing Practice: Changing Standards of Care for Use of CDK4 and 6 Inhibitors in the Treatment of Breast Cancer
July 23, 2020
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Optimizing Precision Medicine in Ovarian Cancer: Expert Insights on Clinical Implications of PARP Inhibitor Therapy and Companion Diagnostics
July 21, 2020
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Practical Perspectives on Rapid Change in Endometrial and Cervical Cancer Management: Exploring Innovative Therapy in Gynecologic Malignancies
July 17, 2020
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
Chair's Take on Harnessing the Immune System in the Treatment of TNBC and Beyond: Where Are We Now and Where Are We Going Next?
July 9, 2020
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
Chair's Take: Latest and Emerging Evidence of PARP Inhibitors in Ovarian Cancer Management
June 18, 2020
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
Chair’s Take on Advances in Gynecologic Cancer Care: Exploring New Advances and Innovative Therapies in Endometrial and Cervical Cancers
June 16, 2020
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
Expert Views on the Evolving Role of PARP Inhibitors in the Treatment of Ovarian Cancer
April 30, 2020
Penn State College of Medicine
Advances in Precision Care in Solid Tumor Oncology: Defining the Role of PARP Inhibitors
November 8, 2019